Related Experiment Video
Updated: Aug 18, 2026

Genetic Engineering of Dictyostelium discoideum Cells Based on Selection and Growth on Bacteria
Published on: January 25, 2019
Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium
Guochun Li1, Hannah Alexander1, Natalie Schneider2
1Division of Biological Sciences, University of Missouri, Columbia, MO 65211, USA1.
Abstract:
The efficacy of the widely used chemotherapeutic drug cisplatin is limited by the occurrence of drug-resistant tumour cells. To fully exploit the potential of this drug in cancer therapy, it is imperative to understand the molecular basis of cisplatin resistance. Using an insertional mutagenesis technique in cells of Dictyostelium discoideum, we have identified six genes which are involved in cisplatin resistance. None of these genes has been previously linked to resistance to this drug. Several of these genes encode proteins that are involved in signal transduction pathways which regulate cell death, cell proliferation or gene regulation. The resistance of these mutant strains is specific for cisplatin, since deletion of these genes does not confer resistance to other DNA-damaging agents. Significantly, the disruption of three of these genes, encoding the sphingosine-1-phosphate lyase, the RegA cAMP phosphodiesterase and a phosphatidylinositol-4-phosphate 5-kinase, also results in abnormalities in the multicellular development of this organism, although there is no change in the rate of mitotic cell growth. This study has identified previously unsuspected molecular pathways which function in the cellular response to cisplatin and are required for normal morphogenesis, and underscores the complexity of the cellular response to cisplatin. These pathways provide potential targets for modulating the response to this important drug.
Insights
Researchers identified six novel genes involved in cisplatin resistance using Dictyostelium discoideum. These genes, some linked to cell signaling and development, offer new targets for overcoming chemotherapy resistance.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Cisplatin is a widely used chemotherapy drug.
- Drug-resistant tumor cells limit cisplatin efficacy.
- Understanding cisplatin resistance mechanisms is crucial for cancer therapy.
Purpose of the Study:
- Identify novel genes involved in cisplatin resistance.
- Investigate the molecular basis of cisplatin resistance.
- Explore potential therapeutic targets for overcoming cisplatin resistance.
Main Methods:
- Insertional mutagenesis technique in Dictyostelium discoideum.
- Identification and characterization of six novel genes conferring cisplatin resistance.
- Analysis of gene function in relation to cell signaling, cell death, proliferation, gene regulation, and multicellular development.
Main Results:
- Six previously unknown genes involved in cisplatin resistance were identified.
- Resistance conferred by these genes is specific to cisplatin.
- Disruption of three genes (sphingosine-1-phosphate lyase, RegA cAMP phosphodiesterase, phosphatidylinositol-4-phosphate 5-kinase) affects multicellular development without impacting cell growth rate.
- Identified novel molecular pathways regulating cellular response to cisplatin and morphogenesis.
Conclusions:
- Novel molecular pathways involved in cisplatin resistance and development have been uncovered.
- These pathways represent potential targets for modulating cisplatin response in cancer therapy.
- The study highlights the complexity of cellular responses to cisplatin and its impact on cellular processes beyond proliferation.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers
Development of Antibiotic Resistance
Other Unique Bacteria

